RUNX2 and cancer: We found that RUNX2, MTA1, or CUL4B depletion inhibited the proliferation of cancer cells, whereas RUNX2, MTA1, or CUL4B overexpression significantly promoted proliferation (Supplementary Fig. 2A–H).